Introduction
It is increasingly clear that reversible thiol modification is a major component of the modulation of cell-signaling pathways by reactive oxygen species (ROS). Superoxide anions result from the partial reduction of oxygen by the mitochondrial electron transport chain ( Jones, 2006) and are subsequently converted to H 2 O 2 either nonenzymatically or by superoxide dismutase. ROS are also generated by activated forms of the enzymes NADPH oxidase, xanthine oxidase, cyclooxygenase, and lipoxygenase (Schneider et al., 2007; Thomas et al., 2008) . In general, the initial product of cysteine oxidation by H 2 O 2 , peroxynitrite, or lipid hydroperoxides is cysteine sulfenic acid, suggesting a pivotal importance for this modification in the response of proteins to ROS. Sulfenic acid-modified proteins can be directly reduced to thiol by cellular reductants or further participate in disulfide bond formation with glutathione or cysteine residues in the same or another protein.
Most evidence of catalytic or regulatory sulfenic acid formation has come from individual studies of purified proteins including peroxiredoxins, organic hydroperoxide resistance protein (Ohr), NADH peroxidase, and methionine sulfoxide reductase (Claiborne et al., 1999; Poole et al., 2004) . The redox status of cysteine has been shown to regulate cellular metabolism through oxidation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cotgreave et al., 2002; Schmalhausen et al., 1999) and MetE (Hondorp and Matthews, 2004) , and to regulate the molecular chaperone activity of HSP33 ( Jakob et al., 1999) and the activity of protein tyrosine phosphatases including PTP1B and PTEN (Tonks, 2005) . Oxidative cysteine modifications have also been shown to control transcriptional regulation by OxyR (Zheng et al., 1998) , OhrR (Fuangthong and Helmann, 2002; Hong et al., 2005; Panmanee et al., 2006) , RsrA (Kang et al., 1999) , Yap1p (Kuge et al., 2001) , and p53 (Rainwater et al., 1995) .
Because cysteine sulfenic acid is unstable in many proteins, studies have been limited by the ability to monitor and identify proteins and sites that have redox-regulated cysteines. To fill this gap, our labs and other groups have developed a series of reagents, based on dimedone, that specifically alkylate and, therefore, trap cysteine sulfenic acids; these chemical probes are or can be linked to affinity or fluorescent tags (Fig. 4 .1) (Leonard et al., 2009; Poole and Nelson, 2008; Poole et al., 2007; Reddie et al., 2008) . These reagents are designed to enable enrichment and sensitive detection of proteins or peptides bearing sulfenic acid modifications. Though sulfenic acids likely represent a dynamic and transient oxidation product, their unique chemistry allows them to be captured by dimedone-based labeling reagents before progression to a potentially more complex array of disulfide-bonded or oxidized products. Even rapid ''trapping'' of sulfenic acids in proteins is still likely to yield substoichiometric amounts of label incorporated into given proteins due to the generally transient nature of the modification. Reliable quantification based on extent of probe incorporation is likely to be difficult propyl 5-((3aR,6S,6aS)-hexahydro-2-oxo-1H-thieno [3,4-d] imidazol-6-yl)pentanoate] is shown in its enol form, reacting with a protein sulfenic acid to generate a stable, alkylated form of the protein (Poole et al., 2007) .
Detection of Protein Sulfenic Acids 97 to achieve, though large time-dependent responses in oxidation for individual cellular proteins may be observed across samples within the same experimental set. Despite these challenges, these probes and techniques represent an important step forward in identifying cysteine residues that are oxidized in cells in response to a particular stimulant. As with phosphorylation sites, all oxidation sites are not expected to have the same role (or for that matter any role) in modulating protein function. Not only may cysteine oxidation be stimulatory, inhibitory, or inconsequential to the activity, stability, or localization of a given protein, but sulfenic acids also have the capacity to go on to form multiple products depending on cellular context that may themselves have different functional effects . The true biochemical evaluation of these sites must ultimately involve both mapping the specific residue being oxidized and evaluating the effect of these oxidations on protein function. We report here some of the potential applications of these sulfenic acidspecific reagents and provide protocols for visualizing and identifying labeled proteins. The previous chapter in this volume provides detailed protocols and controls for labeling both pure and cellular proteins with these probes (Klomsiri et al., 2010) . Although we have developed and used a variety of probes containing fluorescent groups such as rhodamine and fluorescein (Klomsiri et al., 2010; Poole et al., 2007) , we have found that biotin-linked reagents are particularly powerful tools because they allow for affinity capture of the labeled proteins and/or peptides. In this chapter, we provide detailed methods using one of our biotin-tagged reagents, DCPBio1 (Fig. 4 .1) to identify and monitor proteins that are oxidized in vitro and in vivo. We also provide methods to monitor global changes in cysteine sulfenic acid formation.
Biotin-Based Affinity Capture to Identify Proteins Containing Cysteine Sulfenic Acids
The greatest advantage of the biotin-conjugated, sulfenic aciddirected reagents is the ability to use affinity methods to capture the labeled proteins. Because the captured material will be used in many cases to identify labeled proteins and determine the extent of protein labeling, it is very important to ensure that essentially all proteins in the affinity-enriched material contain the biotin modification and are not simply coprecipitating with the labeled proteins. Thus, we have developed a protocol to stringently wash the streptavidin beads prior to elution. In particular, including DTT in one of the washes ensures that unlabeled proteins covalently linked to biotinylated proteins through a disulfide bond will not be included in the eluted material. 
Materials
2.1.1. Solutions 1. 500 mM biotin maleimide in dimethyl sulfoxide (DMSO) 2. 100 mM 1,4-dithio-DL-threitol (DTT) in dH 2 O 3. 100 mM diethylene triamine pentaacetic acid (DTPA) in 1 M sodium hydroxide 4. 25 mM potassium phosphate, pH 7.0, 100 mM DTPA 5. Empty spin columns with $1.2-ml bed volume (e.g., Bio-Spin Chromatography columns from Bio-Rad) 6. Bio-Gel P6 desalting resin (Bio-Rad); 1 ml resin is loaded into empty spin column and equilibrated with 3 column volumes (CV) of buffer 7. Spin column with screw cap and column plug -500-ml bed volume (e. (Poole et al., 2007) ; see accompanying chapter for suggested labeling protocols (Klomsiri et al., 2010) . 2. Salmonella typhimurium AhpC C165S mutant, purified as described previously Poole and Ellis, 1996) and stored at -20 C in 5 mM DTT. Prior to conducting experiments, DTT is removed using a Bio-Gel P6 spin column equilibrated in 25 mM potassium phosphate, pH 7.0, 100 mM DTPA. Alternatively, any other pure protein containing at least one cysteine residue can be used.
Detection of Protein Sulfenic Acids 2.2. Methods 2.2.1. Use of biotinylated AhpC as a procedural control for affinity capture of biotinylated samples To ensure that changes to biotinylation levels between a set of samples is due to physiological changes and not variation in the efficiency of the affinity capture and elution procedure, we add a biotinylated control protein to each sample before affinity capture. We typically use a biotinylated version of the C165S mutant of S. typhimurium AhpC because large amounts of this recombinant protein can be purified in Escherichia coli and because the presence of only one cysteine allows for stoichiometric labeling. This protein is stored in 5 mM DTT, which is removed using a desalting column (i.e., PD10 or Bio-Gel P6). To do this, spin columns (1.2-ml bed volume) containing $1 ml Bio-Gel P6 Resin are equilibrated with 25 mM potassium phosphate, 100 mM DTPA, pH 7.0, centrifuged for 25 min at 1000Âg, and moved to clean, labeled microfuge tubes. Samples are applied to the top, the column is centrifuged for 2 min at 1000Âg, then the material from the flow-through is supplemented with biotin maleimide from a 200 mM stock to a final concentration of 10 mM (DMSO concentration in final solution should be no more than 2%) and incubated at room temperature overnight. Excess biotin maleimide is removed using a second desalting column equilibrated in 25 mM potassium phosphate with 100 mM DTPA, pH 7.0, and the concentration of C165S AhpC is determined based upon absorbance at 280 nm (e ¼ 24,300 M À 1 cm À 1 ). Using this procedure, C165S AhpC was fully labeled with biotin maleimide based upon matrixassisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry (MS) analysis.
Any pure protein can be used for this purpose as long as it contains at least one Cys residue and is not present in the sample to be analyzed. For proteins not stored in DTT, 10 mM DTT should first be added and incubated for 30 min at room temperature prior to the first desalting column and alkylation with biotin maleimide.
Sample preparation to remove unreacted DCP-Bio1 and to
add control protein Cell lysates are labeled with DCP-Bio1 (Poole et al., 2007) according to the protocol described in the preceding chapter (Klomsiri et al., 2010) . In order to prevent further biotinylation of proteins due to nonphysiological oxidation and to prevent free DCP-Bio1 from competing with biotinylated protein for binding to the streptavidin binding sites on the resin, proteins in the cell lysate are separated from small molecules immediately upon thawing. Columns containing $1 ml Bio-Gel P6 resin are equilibrated with 2 CV PBS and 2 CV 2 M urea in PBS, pH 7.2. Columns are centrifuged for 2 min at 1000Âg and moved to clean, labeled microfuge tubes. Cell lysates are applied to the top of each 1-ml column (if samples are more than 0.2 ml, multiple columns are used). Samples are centrifuged for 2 min at 1000Âg and the flow-through material contains the small molecule-free protein. Protein concentrations of each sample are measured using an appropriate assay, such as the BCA Protein Assay (Pierce) or the DC Protein Assay (Bio-Rad). Samples are diluted to 1 mg/ml with urea to a final concentration of 2 M, and biotinylated C165S AhpC (1 mg/500 mg of cell lysate) is added as a procedural control (prepared as described above).
2.2.3.
Capture of biotinylated proteins with stringent washing to prevent coprecipitation of unlabeled proteins For each sample, one spin column (0.5-ml bed volume with screw cap lid) is prepared with nonliganded support beads (i.e., cross-linked agarose, e.g., Sepharose CL-4B) to remove proteins with a tendency to bind nonspecifically to such beads; a second column with streptavidin-agarose beads is also prepared. The binding capacity of the streptavidin beads is used to determine the resin volume needed for the amount of protein being enriched. For Sepharose CL-4B (Sigma) and High Capacity Streptavidin-Agarose Resin (Pierce), 80 ml of resin is used for a typical sample containing 400 mg cell lysate. For HEK293 cells, 400 mg cellular protein can typically be obtained from two 75% confluent, 100-mm dishes harvested with 150 ml lysis buffer per plate. Both columns are equilibrated with 20 CV 2 M urea in PBS, pH 7.2. Immediately prior to adding sample, columns are placed in 1.5-ml microfuge tubes, then centrifuged for 2 min at 1000Âg.
To remove proteins that might bind nonspecifically to the beads, prepared cell lysates are added to the plugged columns containing Sepharose CL-4B beads, the tops are closed with a screw cap lid, columns are sealed into a clean microfuge tube with Parafilm to prevent leaks, and the samples are incubated for 2 h at 4 C with constant rotation. Parafilm and plugs are removed and columns are returned to the tubes, then centrifuged for 1000Âg for 2 min. The flow-through from these columns is transferred to plugged columns containing streptavidin-agarose beads, capped, and sealed into microfuge tubes, and rotated for $16 h at 4 C. Column assemblies are centrifuged at 1000Âg for 2 min to remove unbound proteins.
Beads bound to the biotinylated proteins are washed twice with 4 CV 1% SDS, twice with 4 CV 4 M urea, and twice with 4 CV 1 M NaCl. For each of these solutions, the first wash is incubated with constant rotation for 30 min at 4 C and the second wash is applied for 1 min at room temperature prior to centrifugation. These are followed by additional successive washes at room temperature, once with 4 CV 10 mM DTT in 100 mM ammonium bicarbonate for 5 min, once with 100 mM ammonium bicarbonate without DTT, and twice with 4 CV dH 2 O. For each wash, the beads are resuspended in the wash solution, rotated for the indicated amount of time, centrifuged at Detection of Protein Sulfenic Acids 1000Âg for 2 min, and the supernatant is discarded. The last dH 2 O wash is used to remove any resin from the lid of the column.
Elution conditions depend on the downstream application
Although streptavidin has a high affinity for biotin, various elution conditions can be used (Fig. 4 .2) and should be selected based upon the intended downstream application. We recommend use of an SDS-containing sample buffer for 1D gel electrophoresis. First, the bottom of the column is stoppered, 2.5 CV of 2% SDS in 50 mM Tris-HCl, 1 mM EDTA pH 8.0 is added, the cap is replaced loosely to prevent leakage due to pressure build up, the column is placed inside a clean microfuge tube to collect any sample that might leak, and the whole assembly is heated to 90 C for 10 min (Fig. 4.2 A) . For 2D gel electrophoresis, we recommend adding 2.5 CV of 8 M urea, 2% CHAPS, and 50 mM DTT to the plugged and loosely capped column and heating for 20 min at 37 C, shaking periodically. If the presence of SDS or urea is problematic for downstream applications (e.g., for MS experiments), alternate elution conditions include incubation with 100 mM glycine, pH 2.8 for 10 min at room temperature (Fig. 4.2 A) or proteolytic digestion of the sample while still bound to the streptavidin
SDS Tris
Urea CHAPS GuHCl Glycine SDS Ammonium hydroxide A B Figure 4 .2 Use of various elution conditions to recover biotinylated proteins from streptavidin beads. A. Biotinylated AhpC (180 mg) was incubated with 80 ml streptavidin beads in 250 ml total volume of 2 M urea in PBS, pH 7.2 and incubated for 1.5 h at 24 C. Beads were washed 3 Â0.5 ml 2 M urea in PBS, pH 7.2 and aliquotted into five different tubes prior to centrifugation for 2 min at 1000Âg and removal of the supernatant. Elution solutions (10 ml) were added to each tube and incubated at the appropriate temperature for 10 min. Elution conditions were: 2% SDS in 50 mM Tris-HCl, 1 mM EDTA, pH 8.0 (90 C); 50 mM Tris-HCl, 1 mM EDTA, pH 8.0 (90 C); 8 M urea with 2% CHAPS (37 C); 8 M guanidine hydrochloride (GuHCl) (37 C); and 100 mM glycine, pH 2.8 (24 C). The amount of AhpC protein in 2 ml of the eluted fraction was visualized by Coomassie Blue stain after SDS-PAGE. B. Sulfenic acid-containing C165S AhpC labeled with DCP-Bio1 was incubated with monoavidin beads overnight, washed three times with PBS buffer, and aliquotted into separate tubes. Samples were either incubated with 2.25 M ammonium hydroxide for 16 h at 24 C or boiled in SDS sample buffer containing b-mercaptoethanol for 10 min, and AhpC in the eluant was visualized as in (A).
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Kimberly J. Nelson et al. beads. Because DCP-Bio1 contains an ester linkage, labeled proteins containing the DCP functional group can be cleaved from the biotin moiety by incubation with 2.25 M ammonium hydroxide for $16 h at 24 C (Fig. 4.2 B) . For all elution conditions, the spin column is centrifuged at 1000 Â g for 3 min and the flow-through is retained.
Detection Methods to Identify Oxidized Proteins and Cysteines
Potential uses for sulfenic acid-specific trapping agents include monitoring of cysteine oxidation of a particular protein under various conditions (targeted approaches), following cysteine oxidation of total cellular proteins in response to various stimuli (global approaches), and identifying novel proteins with redox sensitive cysteine residues (proteomic approaches). In this section, we provide protocols suitable for all of these approaches. Although we briefly touch on techniques including Western blots, immunoprecipitation (IP), and MS analysis, detailed protocols for these are only given for the proteins studied herein, and we focus on how these techniques can be adapted to identify and monitor proteins labeled with DCP-Bio1 and related compounds. Time-dependent changes in protein sulfenic acid levels in HEK293 cells, analyzed by Western blot analyses of the affinity-captured material, show that phosphatases (PTEN and SHP-2), kinases (protein kinase C, PKC-b1), chaperones (heat shock protein, HSP70), and glycolytic enzymes (GAPDH) are all transiently oxidized and labeled by DCP-Bio1 in tumor necrosis factor-a (TNFa) treated cells (Fig. 4.3) . Some of the proteins we observe, such as GAPDH, are known to form a stabilized sulfenic acid, and others (PTEN, SHP-2, and HSP70) are known to be redox regulated, though not specifically through sulfenic acid formation. The signaling phosphatases PTEN (Kwon et al., 2004; Lee et al., 2002) and SHP-2 (Chen et al., 2006; Kwon et al., 2005; Meng et al., 2002) are known to be oxidation sensitive, with the former yielding an intrasubunit disulfide bond between the active site Cys (Cys124) and Cys71; sulfenic acid formation has been postulated based on other protein tyrosine phosphatases (Tonks, 2005) , but not fully demonstrated in each case. In the case of HSP70, protein S-glutathionylation in retinal pigment epithelium has been shown to convert this protein to an active chaperone (Hoppe et al., 2004) .
3.1.
We note from our blots (Fig. 4. 3) that patterns of oxidation differ between proteins in the same experimental samples, suggesting distinct influences on oxidation status of various proteins after cell stimulation. Because each protein exhibits a different profile (Fig. 4.3 
7.
Antibiotin antibody and HRP-conjugated secondary antibody (or streptavidin-HRP conjugate) 8. 5% (w/v) dried milk in TBST 9. 1% BSA in TBST 3.2.2. Methods The previous section described performing a Western blot on the affinitycaptured biotinylated samples to look for the target protein; an alternate and complementary approach is to immunoprecipitate the target protein, then probe the samples for biotin. Use of both techniques gives the strongest evidence that a given protein is indeed labeled by the biotinylated reagent as long as proper controls in the absence of reagent are included. Western blot analysis. HEK293 cells were stimulated with TNFa for the indicated amount of time, cells were washed with PBS, and sulfenic acids were trapped by the addition of lysis buffer containing 1 mM DCP-Bio1, 10 mM N-ethylmaleimide, 10 mM iodoacetamide, 200 U/ml catalase, 100 mM NaCl, 100 mM DTPA, 20 mM b-glycerophosphate, 1 mM sodium vanadate, 50 mM sodium fluoride, 1 mM PMSF, 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin, 0.1% sodium dodecyl sulfate, 0.5% sodium deoxycholate, 0.5% NP-40, and 0.5% Triton-X-100 in 50 mM Tris-HCl, pH 7.5, incubated on ice for 1 h, and stored at À80 C. Biotinylated proteins were affinity captured according to the protocol described in methods, then separated by SDS-PAGE and transferred to a nitrocellulose membrane. The extent of cysteine oxidation on individual proteins was evaluated using protein-specific antibodies. Biotin-labeled AhpC was added based on protein concentrations prior to affinity capture and used as a procedural control for the biotin-based affinity capture, elution and gel loading steps. Antibodies to HSP70, PKC-b1, and GAPDH were from Santa Cruz; antibodies to PTEN and SHP-2 were from Cell Signaling, and the AhpC antibody was purified from rabbit serum.
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IP is performed according to established protocols specific to the protein of interest. After beads have been incubated with the protein samples, they are washed with PBS or more stringent conditions (if possible), then eluted with SDS sample buffer. Biotin blots are then performed on the eluted, electrophoresed samples using either HRP-conjugated streptavidin or antibiotin antibodies. In our hands, antibiotin antibodies perform somewhat better. In order to avoid coelution of the antibody proteins, antibodies may be crosslinked to the beads prior to IP. Otherwise, a control for the antibody without lysate should be included as we have observed biotinylation of the antibody subunits and these can mask detection of the target protein if of similar size.
Using this approach, we were able to clearly demonstrate the presence of biotinylated proteins at the correct molecular weight in the IPs of PTEN and SHP-2 proteins (Fig. 4.4) , confirming the data using the affinitycaptured material that identified these two proteins as sulfenic acid-containing proteins. For IP experiments shown in Fig. 4 .4, TNFa-treated HEK293 lysates were preincubated with 20 ml Dynabeads-Protein A magnetic beads preequilibrated in PBS and then incubated overnight at 4 C with 0.5 ml of either anti-PTEN or anti-SHP-2 antibody (Cell Signaling) and 20 ml Dynabeads-Protein A magnetic beads. The supernatant was then removed and the beads were washed three times with PBS buffer. Immunoprecipitated proteins were eluted with 35 ml SDS-PAGE-loading buffer and biotinylated proteins were visualized using Streptavidin-HRP.
Controls for endogenous biotinylation
The biotin affinity capture and detection procedures described herein (with the exception of MS analysis) cannot distinguish between proteins labeled with a biotinylated chemical reagent and those that are endogenously biotinylated on lysine. To test for endogenous biotinylation, it is important to include a sample that has not been labeled with the biotin compound as a control in all experiments (Fig. 4.4) .
Global approaches: Identification of overall sulfenic acid levels for cellular proteins in response to stimuli
In order to estimate the relative of abundance proteins containing sulfenic acid in the cellular proteome under various conditions, we have used both biotinylated and fluorescent reagents. In addition to the affinity-based methods employed above, global biotin incorporation can be visualized using gel-based techniques such as total protein staining of gels following affinity capture of biotinylated proteins (Fig. 4 .5 A ) and antibiotin Western blots using either a streptavidin-HRP conjugate or an antibiotin antibody (Fig. 4.5 B) . We have also labeled lysates with DCP-FL1, a dimedone analogue containing a fluorescein moiety (as well as other fluorescent compounds including DCP-FL2, DCP-Rho1, and DCP-Rho2) and have visualized sulfenic acid-modified proteins both in 1D (not shown) and 2D gels using a fluorescence imager (Fig. 4.5 C) . Finally, we have used a FluoReporter biotin incorporation assay to evaluate total biotin incorporation into cellular proteins (Fig. 4.5 D) . ) labeling is established by immunoblots to SHP-2 and PTEN after biotin affinity capture (biotin AC) and by visualizing biotinylated proteins after immunoprecipitation (IP) of SHP-2 and PTEN, but these proteins are not endogenously biotinylated. HEK293 cells were grown in DMEM media containing 10% FBS and exchanged into serum-free DMEM media for 30 min prior to the addition of the 5 mM DCP-Bio1-containing lysis buffer and incubation (see Fig. 4 .3). Cell lysates were centrifuged at 14,000Âg for 10 min, and the protein concentration in each supernatant was determined using the BCA protein assay. For immunoprecipitation, lysates (175 mg of protein each) were preincubated for 1 h at 4 C with 20 ml DynabeadsProtein A magnetic beads preequilibrated in PBS (but lacking antibody) to remove nonspecifically associating proteins, then supernatants were transferred to tubes containing 0.5 ml of either anti-PTEN or anti-SHP-2 antibody (Cell Signaling) and a fresh aliquot (20 ml) of magnetic beads and incubated overnight at 4 C. Supernatants were then removed and the beads were washed three times with PBS buffer. Immunoprecipitated proteins were eluted with 35 ml SDS sample buffer. Affinity capture of biotinylated proteins was conducted according to the protocol described in methods. Proteins (10 ml per sample) were separated by SDS-PAGE in 10% polyacrylamide gels, transferred to nitrocellulose membrane, and blocked with 5% milk. For immunoblotting, membranes were incubated for 2 h at 24 C with a 1:10,000 dilution of streptavidin-HRP or for 16 h at 4 C with a 1:1000 dilution of either anti-SHP-2 (A, Cell Signaling) or anti-PTEN antibodies (B, Cell Signaling), then visualized with Pico chemiluminescent substrate (Pierce). To visualize protein bands in samples after affinity capture of biotinylated proteins, HEK293 cells were treated (or not) with 100 nM insulin for 2 min, then sulfenic acids were trapped with 1 mM DCP-Bio1 in lysis buffer as in Fig. 4 .3. Streptavidin-agarose beads were used to capture biotinylated proteins from lysates, then extensively washed with 1% SDS, 4M urea in PBS, 1 M NaCl, 100 mM ammonium bicarbonate and dH 2 O. Proteins were eluted with 2% SDS in 50 mM Tris-HCl, pH 8.0, 1 mM EDTA, separated by SDS-PAGE, and stained with SYPRO Ruby (Pierce). Proteins showing increased sulfenic acid labeling in response to insulin are marked with arrows. (B) To blot for biotin after separation of total protein samples on gels, HEK293 cells were treated (or not) with TNFa for the indicated amount of time, then sulfenic acids were trapped with 1 mM DCP-Bio1 in lysis buffer. Unreacted DCP-Bio1 was removed using a Bio-Gel P6 spin column and 20 mg of protein from each sample was separated on a 10% SDS-PAGE followed by transfer to nitrocellulose. Membranes were blocked overnight with 5% milk, incubated with a 1:1000 dilution of antibiotin, HRP-conjugated antibody (Cell Signaling) for 2 h at 24 C, and visualized with Pico chemiluminescence kit. As a loading control, 10 mg of each sample was probed for actin using an anti-actin antibody (Cell Signaling). (C) For protein analyses using 2D gels, HEK293 cells were treated with TNFa or insulin and labeled with 1 mM DCP-FL1. Proteins were precipitated with cold acetone, washed with 10% TCA and 1:1 ether:ethanol, and then resolubilized in 8 M urea, 2% CHAPS, 50 mM DTT, and 0.2% ampholytes. Proteins were separated by 2D electrophoresis using pH 3-10 IPG strips (BioRad), followed by 4-20% Criterion For gel-based analyses of proteins labeled with fluorescent analogues, it is often preferable to first remove excess reagent either by passing lysates through a Bio-Gel P6 spin column, or by precipitating proteins and washing the pellets before resuspension into sample buffer. After electrophoresis, gels can be fixed with 10% acetic acid, 40% methanol and washed at least three times with water prior to visualization. For fluorophores such as fluorescein which are less fluorescent at low pH, fixed gels are washed two times for 15 min each with 40 mM ammonium bicarbonate, pH 8.0.
Detection of Protein Sulfenic Acids
For separation of either biotinylated or fluorescently labeled proteins by 2D electrophoresis, it is important to ensure that samples not contain any excess reagents or salts as either of these may interfere with isoelectric focusing. Therefore, samples (up to 200 ml) are precipitated with 1 ml cold acetone, incubated on ice for 10 min and centrifuged at 14,000Âg for 10 min at 4 C. Supernatants are removed, the pellets are washed with 0.5 ml 10% trichloroacetic acid, then samples are centrifuged again and washed one more time with 200 ml of 1:1 ether:ethanol. Liquid is removed and pellets are allowed to air dry prior to the addition of an appropriate buffer for isoelectric focusing (e.g., 8 M urea 2% CHAPS). Sample resuspension is allowed to proceed at 37 C for 20-60 min with occasional tapping. Protein content is measured, then ampholytes and DTT (10 ml of a freshly prepared 1 M stock per 200 ml final volume) are added to the samples just prior to their application onto isoelectric focusing strips. For 2D gels of affinity-captured, biotinylated samples, we typically use samples derived from 0.4 to 1 mg of starting lysate.
We have used the FluoReporter biotin assay kit from Invitrogen to evaluate biotin incorporation into total protein, an assay which measures the increase in fluorescence as biotin displaces quencher dye from the biotin binding sites on their Biotective TM Green reagent. For this and all assays designed to measure biotin, unreacted DCP-Bio1 and other small molecules must first be removed using a Bio-Gel P6 spin column and the samples exchanged into PBS or another buffer compatible with the assay of interest. Following the directions in the kit, cell lysates ($10-25 mg total protein in 50-ml volume) are digested with a protease to disrupt protein structure and allow protein-bound biotin to access the binding sites on the dye (Fig. 4.5 D) .
gel (BioRad), and fluorescein labeled proteins were visualized on a Amersham STORM 840 fluorescence imager. (D) A FluoReporter biotin quantitation assay kit (Invitrogen) was used to quantify the amount of biotin incorporation into HEK293 cells before and after stimulation with TNFa for 10 min. Briefly, cell lysates ($ 10-25 mg) were digested with Streptomyces griseus Protease type XIV overnight at 37 C and diluted in PBS until each sample contained 1-2 mg total protein. After incubation for 5 min at room temperature in the dark with an equal volume of Biotective Green reagent, fluorescence was measured on a Tecan Safire 2 fluorescence plate reader using l ex ¼ 485 nm and l em ¼ 530 nm.
The FluoReporter assay is able to detect between 4 and 80 pmol of biotin per 50-ml sample, and the digestion mixture will most likely need to be diluted for samples to be in the correct range; for our experiments, 1-2 mg total protein per sample was a good starting amount. A standard curve is generated using a small molecule biotin provided in the kit; the standard curve should include 2-3 replicates of a zero and a minimum of four other biotin concentrations. Analysis of a biotinylated protein used as a positive control is also recommended in order to confirm that proteolysis is sufficient to yield assayaccessible biotin. Each sample is incubated with 50 ml of Biotective Green reagent in a 96-well plate for 5 min at room temperature in the dark. Sample fluorescence is measured on a fluorescence plate reader using l ex ¼ 485 nm and l em ¼ 530 nm.
For all of these assays, it is important to gauge the endogenous levels of biotinylation on lysine. Studies in our laboratory to date indicate that these levels are very low when compared with the amount of DCP-Bio1 incorporation, but some prominent bands are present even when no biotin is added (see Fig. 3 .5B in the preceding chapter, Klomsiri et al., 2010) .
3.5. Global approaches: Identification of oxidized proteins by mass spectrometry after biotin affinity capture Biotinylated samples can be used for proteomic level analyses in order to identify unknown proteins with peroxide-sensitive cysteines. In order to minimize false positives and to simplify analysis, we suggest performing affinity capture along with stringent washing procedures on such biotinylated samples. For these types of studies, the affinity-captured material is generally separated by 1D or 2D electrophoresis followed by in-gel proteolysis and standard MS analyses to identify the proteins (Shevchenko et al., 2006) Table 4 .1 lists a selection of proteins that we have identified from lysates, derived from TNFatreated HEK-293 cells, using biotin-based affinity capture, separation by either 1D or 2D gel electrophoresis, in-gel proteolytic digestion, and MS analysis.
Identification of oxidized cysteine by MS-MS analysis
Although stringent washing of the streptavidin beads may help minimize the identification of false positives, the ultimate proof that a protein truly contains an oxidized cysteine comes from the direct identification of the oxidized cysteine. For this purpose, affinity capture of biotinylated peptides can be performed after proteolytic digestion of the cellular proteins (Dennehy et al., 2006; Shin et al., 2007) . Alternatively, biotinylated proteins can first be enriched by affinity purification, then digested and further enriched for biotinylated peptides using a second affinity capture step. We have used the first type of experiment to identify the labeled cysteine residue in peroxiredoxin VI using a DCP-Bio1-treated lysate of HEK-293 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate (TPA). This peptide was identified by performing a tryptic digest, biotin-based affinity capture of the labeled peptides, and LC-MS/MS analysis (Fig. 4.6 ). Because this method is only expected to capture 1 or a few peptides per protein, the results will be heavily influenced by the choice of protease. For this reason, it may be desirable to use more than one protease for each sample in order to increase the number of peptides identified. 
Summary
Reagents developed recently by us and others have provided a new set of tools to specifically trap the largely unstable protein sulfenic acid intermediate in cellular proteins. Using protocols optimized to minimize the presence of unlabeled proteins in our affinity-captured material, it is now possible to identify proteins and specific cysteine residues that are oxidized Figure 4 .6 LC/MS/MS spectrum of a DCP-Bio1-labeled tryptic peptide from PrxVI labeled on the reactive Cys residue, Cys46. HEK293 cells were grown in DMEM media to 80% confluence, serum-starved for 20 h, and treated with 100 nM TPA for 1 min. Cells were scraped, then lysed in lysis buffer containing 5 mM DCP-Bio1 and 10 mM NEM and incubated at room temperature for 30 min; proteins in the sample were further treated under denaturing conditions by adding urea to 6M and incubating for 10 min with 10 mM DTT, then adding NEM to 20 mM for another 35 min incubation. To remove excess labeling agents and protease inhibitors, the sample was exchanged into digestion buffer (2 M urea, 100 mM ammonium bicarbonate) using a G-25 spin column. Trypsin was added (1:100, w/w) and incubated at 37 C for 15 h. Excess trypsin and undigested protein was removed by passing peptides through a 5000 molecular weight cut-off Ultrafree-MC centrifugal filter (Millipore) following digestion. For biotin affinity capture, peptides were incubated with a preequilibrated monoavidin resin (from Pierce) at 4 C overnight. The beads were washed several times with additional urea/bicarbonate buffer, followed by 10 mM ammonium bicarbonate, then water. Peptides were eluted with 30% acetonitrile containing 500 mM formic acid, then concentrated in a SpeedVac before analysis. Reverse phase chromatography on a C-18 column was used to resolve peptides, with a portion of the eluant injected directly into the LTQ mass spectrometer. As illustrated above, cleavage of the amide bond results in N-terminal fragments designated as ''b'' and C-terminal fragments designated as ''y''. The masses of both sets of ions are consistent with DCP-Bio1 linked covalently to Cys46 of human peroxiredoxin VI (PrxVI) (y7 À y6 ¼ b6 À b5 ¼ 498.5 m/z).
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Kimberly J. Nelson et al. in response to cellular stimulation and to monitor the conditions under which these oxidations occur. The protocols presented here are suitable for the large-scale identification of these modified proteins by high-throughput proteomics methods, yet can also be employed to investigate the oxidation of a particular protein or system by a lab with limited access to MS. Although the presence and location of an oxidized cysteine often does not directly indicate whether it modulates protein function, it is an important first step. Once the oxidized cysteine has been identified, future experiments can be designed that explore the role of these oxidations on protein function and cellular processes.
